Edition:
United States

Obalon Therapeutics Inc (OBLN.OQ)

OBLN.OQ on NASDAQ Stock Exchange Global Market

7.85USD
15 Dec 2017
Change (% chg)

$0.03 (+0.38%)
Prev Close
$7.82
Open
$7.74
Day's High
$7.90
Day's Low
$7.74
Volume
42,516
Avg. Vol
9,653
52-wk High
$13.18
52-wk Low
$7.14

Chart for

About

Obalon Therapeutics, Inc. is a United States-based commercial-stage medical device company focused on developing and commercializing medical devices to treat obese and overweight people by facilitating weight loss. The Company's product, Obalon balloon system, is a swallowable, gas-filled intragastric balloon designed to provide... (more)

Overall

Beta: --
Market Cap(Mil.): $136.92
Shares Outstanding(Mil.): 17.44
Dividend: --
Yield (%): --

Financials

  Industry Sector
P/E (TTM): -- 60.10 16.04
EPS (TTM): -- -- --
ROI: -- 13.32 34.69
ROE: -- 19.86 15.46

BRIEF-Obalon Therapeutics Q3 loss per share $0.55

* Q3 earnings per share view $-0.45 -- Thomson Reuters I/B/E/S Source text for Eikon: Further company coverage:

Nov 03 2017

BRIEF-Obalon Therapeutics & Sono Bello announce agreement to offer novel weight loss treatment

* Obalon Therapeutics Inc and Sono Bello announce agreement to offer novel weight loss treatment in Sono Bello centers

Nov 02 2017

BRIEF-Obalon Therapeutics files for mixed shelf of up to $100 mln

* Says in addition, selling stockholder may offer and sell up to 150,000 shares of co's common stock Source text: http://bit.ly/2z5bZGj Further company coverage:

Nov 01 2017

BRIEF-Obalon Q2 loss per share $0.46

* Q2 earnings per share view $-0.44 -- Thomson Reuters I/B/E/S

Aug 02 2017

Earnings vs. Estimates